Research programme: peptide-based theranostics - Nihon Medi-Physics/PeptiDream
Alternative Names: Peptide-drug conjugate theranostics - Nihon Medi-Physics/PeptiDream; Peptide-radioisotope conjugate theranostics - Nihon Medi-Physics/PeptiDreamLatest Information Update: 11 Apr 2025
At a glance
- Originator Nihon Medi-Physics; PeptiDream
- Class Drug conjugates; Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters; Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 31 Mar 2025 Nihon Medi-Physics has been acquired by GE Healthcare
- 28 Jan 2023 No recent reports of development identified for research development in Unspecified in Japan
- 28 Jan 2023 No recent reports of development identified for research development in Unspecified(Diagnosis) in Japan